Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator

Summary

This study will look at what happens to the level of protection against hepatitis B (HB) disease if a 'helper' gel is applied to the skin over the injection site of a small dose of hepatitis B vaccine.

Timeline

Start

2005-08

Primary completion

2007-04

Completion

2007-04

Drugs

Indications